Breast Cancer Trial, Recruiting NCT07396766 Sponsor: UNC Lineberger Comprehensive Cancer Center Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07396766
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older at the time of agreeing to participate
  • People who are able to read and speak English
  • People who have had breast surgery, such as a mastectomy (full breast removal) or lumpectomy (partial breast removal), to remove some or all of one or both breasts
  • People whose breast surgery took place within the last 8 years
  • People whose breast surgery was done because of a diagnosis of breast cancer, ductal carcinoma in situ (an early form of breast cancer), or because of a high risk of developing breast cancer in the future (based on what the participant reports)
  • People who were assigned female at birth

Who may not be able to join:

  • People who have unstable medical or mental health conditions that would make it difficult to give informed consent or take part in the study, whether self-reported or observed by others

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Clara Lee, UNC Lineberger Comprehensive Cancer Center

Phone: 919-966-4320

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
UNC Lineberger Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
20 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in breast reconstruction knowledge

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov